person · Reporting owner

Leproust Emily M.

Disclosed activity across 2 companies

Tapewire entity: 19007
SEC CIK: 0001753655

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
GeneDx Holdings Corp.WGS · Entity 1634	Director	June 18, 2026	June 23, 2026
Twist Bioscience CorpTWST · Entity 3619	Director · Chief Executive Officer	October 05, 2026	October 07, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

GeneDx Holdings Corp.

Report date June 18, 2026 · Filed June 23, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	24,852	Reported balance After 2026-06-18 transaction · row 1 1 source row Row 1 · 2026-06-18 · Exercise / conversion · Acquired 3,576 · Balance 24,852 F1: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	4,248	Reported balance After 2026-06-18 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-18 · Grant · Acquired 4,248 · Balance 4,248 F1: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F2: The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-06-18 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-06-18 · Exercise / conversion · Disposed 3,576 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F3: The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

F2: The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

F3: The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

Twist Bioscience Corp

Report date October 05, 2026 · Filed October 07, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	562,760	Ending reported balance After 2026-10-05 transaction · row 8 8 source rows · reconciled sequence Row 1 · 2026-10-05 · Sale · Disposed 1,840 · Balance 565,468 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $200 to $200.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 2 · 2026-10-05 · Sale · Disposed 481 · Balance 564,987 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $201 to $201.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 3 · 2026-10-05 · Sale · Disposed 1,017 · Balance 563,970 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $202 to $202.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 4 · 2026-10-05 · Sale · Disposed 432 · Balance 563,538 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $203.29 to $203.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 5 · 2026-10-05 · Sale · Disposed 290 · Balance 563,248 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $204.33 to $205.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 6 · 2026-10-05 · Sale · Disposed 297 · Balance 562,951 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $205.37 to $206.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 7 · 2026-10-05 · Sale · Disposed 146 · Balance 562,805 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $206.38 to $207.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 8 · 2026-10-05 · Sale · Disposed 45 · Balance 562,760 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026. F9: Represents the weighted average sales price per share. The shares sold at prices ranging from $207.38 to $207.8 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.33 · Expires 2029-10-23	Direct	131,290	Reported balance Holding disclosure · report date 2026-10-05 · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · Balance 131,290 F10: 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.85 · Expires 2030-08-31	Direct	64,950	Reported balance Holding disclosure · report date 2026-10-05 · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · Balance 64,950 F11: Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.

Filing footnotes · ownership attribution and instrument terms

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 15, 2026.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $200 to $200.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $201 to $201.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $202 to $202.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $203.29 to $203.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $204.33 to $205.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $205.37 to $206.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $206.38 to $207.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F9: Represents the weighted average sales price per share. The shares sold at prices ranging from $207.38 to $207.8 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F10: 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F11: Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 14, 2021 Filed Jun 16, 2021 21:20 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	1,100	$112.38	$123,619.65	Disclosure SEC source: 0001214659-21-006635 · marketforms-53144.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,886 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $111.81 to $112.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
May 20, 2021 Filed May 24, 2021 21:15 UTC	Twist Bioscience Corp TWST · Entity 3619	Tax withholdingCommon Stock	2,903	$97.75	$283,768.25	Disclosure SEC source: 0001214659-21-005866 · marketforms-52896.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,986 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document
May 12, 2021 Filed May 13, 2021 20:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	200	$97.10	$19,419.00	Disclosure SEC source: 0001214659-21-005306 · marketforms-52762.xml · nonDerivative · entry 4 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,889 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $96.92 to $97.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
May 12, 2021 Filed May 13, 2021 20:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	400	$95.49	$38,196.00	Disclosure SEC source: 0001214659-21-005306 · marketforms-52762.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,089 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $95.14 to $95.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
May 12, 2021 Filed May 13, 2021 20:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	700	$94.08	$65,855.02	Disclosure SEC source: 0001214659-21-005306 · marketforms-52762.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,489 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $93.81 to $94.46 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
May 12, 2021 Filed May 13, 2021 20:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	700	$92.96	$65,071.02	Disclosure SEC source: 0001214659-21-005306 · marketforms-52762.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,189 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $92.35 to $93.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
April 23, 2021 Filed Apr 27, 2021 21:25 UTC	Twist Bioscience Corp TWST · Entity 3619	Tax withholdingCommon Stock	954	$133.12	$126,996.48	Disclosure SEC source: 0001214659-21-004543 · marketforms-52310.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,889 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document
April 12, 2021 Filed Apr 15, 2021 10:49 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	200	$132.39	$26,477.00	Disclosure SEC source: 0001214659-21-004193 · marketforms-52246.xml · nonDerivative · entry 5 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,843 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $132.30 to $132.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
April 12, 2021 Filed Apr 15, 2021 10:49 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	300	$129.84	$38,952.99	Disclosure SEC source: 0001214659-21-004193 · marketforms-52246.xml · nonDerivative · entry 4 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,043 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $129.64 to $129.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
April 12, 2021 Filed Apr 15, 2021 10:49 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	899	$129.00	$115,966.68	Disclosure SEC source: 0001214659-21-004193 · marketforms-52246.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,343 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $128.49 to $129.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
April 12, 2021 Filed Apr 15, 2021 10:49 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	300	$127.30	$38,190.99	Disclosure SEC source: 0001214659-21-004193 · marketforms-52246.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,242 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $127.15 to $127.61 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
April 12, 2021 Filed Apr 15, 2021 10:49 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	301	$125.67	$37,826.25	Disclosure SEC source: 0001214659-21-004193 · marketforms-52246.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,542 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $125.13 to $126.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
April 01, 2021 Filed Apr 5, 2021 22:34 UTC	Twist Bioscience Corp TWST · Entity 3619	Tax withholdingCommon Stock	713	$122.20	$87,128.60	Disclosure SEC source: 0001214659-21-003958 · ownership.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,843 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document
April 01, 2021 Filed Apr 7, 2021 14:50 UTC	Twist Bioscience Corp TWST · Entity 3619	Tax withholdingCommon Stock	713	$122.20	$87,128.60	Disclosure SEC source: 0001214659-21-003996 · marketforms-52192.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,843 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document
March 12, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	900	$141.76	$127,584.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 8 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,556 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $141.33 to $142.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
March 12, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	200	$140.22	$28,044.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 7 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,456 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.96 to $140.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
March 12, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	200	$139.25	$27,849.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 6 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,656 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $138.87 to $139.62 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
March 12, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	200	$137.81	$27,561.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 5 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,856 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.74 to $137.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
March 12, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	500	$136.79	$68,397.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 4 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,056 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $136.32 to $137.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
February 25, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	GiftCommon Stock	5,000	$0.00	$0.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,556 Read SEC document
February 25, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	GiftCommon Stock	20,000	$0.00	$0.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,556 Read SEC document
February 25, 2021 Filed Mar 16, 2021 21:35 UTC	Twist Bioscience Corp TWST · Entity 3619	GiftCommon Stock	20,000	$0.00	$0.00	Disclosure SEC source: 0001214659-21-003192 · marketforms-51893.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,556 Read SEC document
February 19, 2021 Filed Feb 23, 2021 23:56 UTC	Twist Bioscience Corp TWST · Entity 3619	Tax withholdingCommon Stock	3,007	$150.81	$453,485.67	Disclosure SEC source: 0001214659-21-002301 · marketforms-51557.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,556 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:53 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	500	$170.64	$85,320.00	Disclosure SEC source: 0001214659-21-002031 · marketforms-51489.xml · nonDerivative · entry 6 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,188 F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $170.03 to $170.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:53 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	100	$169.00	$16,900.00	Disclosure SEC source: 0001214659-21-002031 · marketforms-51489.xml · nonDerivative · entry 5 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,688 Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:53 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	300	$167.78	$50,333.01	Disclosure SEC source: 0001214659-21-002031 · marketforms-51489.xml · nonDerivative · entry 4 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,788 F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $167.62 to $167.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:53 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	600	$167.19	$100,316.88	Disclosure SEC source: 0001214659-21-002031 · marketforms-51489.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,088 F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $166.60 to $167.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:53 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	100	$165.30	$16,530.00	Disclosure SEC source: 0001214659-21-002031 · marketforms-51489.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,688 Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:53 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	400	$164.70	$65,878.00	Disclosure SEC source: 0001214659-21-002031 · marketforms-51489.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,788 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $164.01 to $165.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	100	$181.09	$18,109.00	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 9 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	2,406	$180.62	$434,567.15	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 8 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 100 F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $180.08 to $181.06 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	5,089	$179.55	$913,744.71	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 7 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,506 F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $179.06 to $180.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	7,020	$178.54	$1,253,380.28	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 6 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,595 F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $178.05 to $179.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	12,589	$177.48	$2,234,261.73	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 5 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,615 F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $177.04 to $178.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	6,540	$176.47	$1,154,111.84	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 4 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 27,204 F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $176.03 to $177.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
February 09, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	41,256	$175.29	$7,231,578.59	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 33,744 F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $175.00 to $175.98 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
January 22, 2021 Filed Jan 26, 2021 22:48 UTC	Twist Bioscience Corp TWST · Entity 3619	Tax withholdingCommon Stock	1,008	$190.64	$192,165.12	Disclosure SEC source: 0001214659-21-000825 · marketforms-51258.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,188 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document
January 20, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	200	$211.09	$42,218.92	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 7 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,196 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $211.02 to $211.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 20, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	2,000	$210.30	$420,609.00	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 6 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,396 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $210.15 to $210.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 20, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	2,800	$209.22	$585,808.16	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 5 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,396 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $209.00 to $209.49 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 20, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	GiftCommon Stock	75,000	$0.00	$0.00	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 75,000 F1 · kind: This transaction involved a gift of securities by the Reporting Person to her spouse. F2 · kind: Change in form of ownership of shares previously reported as beneficially owned by the reporting person. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of such shares. Read SEC document
January 20, 2021 Filed Feb 11, 2021 21:38 UTC	Twist Bioscience Corp TWST · Entity 3619	GiftCommon Stock	75,000	$207.97	$15,597,750.00	Disclosure SEC source: 0001214659-21-001554 · marketforms-51449.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,188 F1 · kind: This transaction involved a gift of securities by the Reporting Person to her spouse. F2 · kind: Change in form of ownership of shares previously reported as beneficially owned by the reporting person. Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	400	$202.01	$80,802.00	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 4 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,196 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $202.00 to $202.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	6,811	$201.26	$1,370,773.01	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,596 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $201.00 to $201.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	6,146	$200.49	$1,232,185.11	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,407 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $200.00 to $200.96 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	6,643	$199.36	$1,324,371.73	Disclosure SEC source: 0001214659-21-000706 · marketforms-50967.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,553 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $199.00 to $199.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 14, 2021 Filed Jan 19, 2021 22:02 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	5,000	$189.08	$945,386.50	Disclosure SEC source: 0001214659-21-000629 · marketforms-50945.xml · nonDerivative · entry 3 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,196 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $189.00 to $189.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 14, 2021 Filed Jan 19, 2021 22:02 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	593	$180.17	$106,838.20	Disclosure SEC source: 0001214659-21-000629 · marketforms-50945.xml · nonDerivative · entry 2 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,196 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $180.03 to $180.24 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 14, 2021 Filed Jan 19, 2021 22:02 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	4,407	$179.52	$791,130.98	Disclosure SEC source: 0001214659-21-000629 · marketforms-50945.xml · nonDerivative · entry 1 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,789 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $179.00 to $179.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
January 12, 2021 Filed Jan 14, 2021 21:30 UTC	Twist Bioscience Corp TWST · Entity 3619	SaleCommon Stock	100	$172.67	$17,267.00	Disclosure SEC source: 0001214659-21-000502 · marketforms-50928.xml · nonDerivative · entry 11 Leproust Emily M. · CIK 0001753655 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,196 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.